Study details
Enrolling now
PT150 Drug for Alcohol Use Disorder
Pop Test Oncology LLC
NCT IDNCT06712602ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
34
Study length
about 3.5 years
Ages
21–55
Locations
1 site in KY
About this study
This trial is testing if PT150 can reduce the effects of stress, alcohol, and alcohol use in people with alcohol use disorder. It involves behavioral testing and measuring responses to a cold water stressor (CPT).
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Stress-Induction
- 2.Take PT150
- 3.Take alcohol
PhasePhase 1
Drugalcohol
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low10%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ethanol
Endpoints
Secondary: Change in Heart Rate (Alcohol), Change in Heart Rate (Stress), Change in blood pressure (alcohol), Change in blood pressure (stress)
Body systems
Psychiatry / Mental Health